CVS Health Current Ratio

CVS Health Corporation -- USA Stock  

USD 79.35  0.51  0.64%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Current Ratio Analysis

Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
CVS Health 
Current Ratio 
Current Asset 
Current Liabilities 
1.05 times

Distress Driver Correlations

 CVS Health Current Ratio 

About Current Ratio

Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e. Current Ration of 2 to 1).
Compare to competition


CVS Health Income Change Over Time

Accumulated Other Comprehensive Income

In accordance with recently published financial statements CVS Health Corporation has Current Ratio of 1.05 times. This is 63.92% lower than that of the Healthcare sector, and significantly higher than that of Healthcare Services industry, The Current Ratio for all stocks is 68.18% higher than the company.

Peer Comparison

CVS Health Current Ratio Comparison
  Current Ratio 
      CVS Health Comparables 
CVS Health is rated fifth in current ratio category among related companies.

Did you try this?

Run Analyst Recommendations Now

Analyst Recommendations

Analyst recommendations and target price estimates broken down by several categories
Hide  View All  NextLaunch Analyst Recommendations